Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Menopause01:28

Menopause

143
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
143
Oogenesis02:07

Oogenesis

63.5K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.5K
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

333
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
333
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

312
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
312
Menses Phase01:18

Menses Phase

241
The uterine cycle begins with the menstrual phase, which is considered day one of the cycle and typically lasts about five days. This phase is characterized by the degeneration and shedding of the stratum functionalis, the functional layer of the endometrium.
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
241
Ovarian Cycle01:27

Ovarian Cycle

1.1K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Multidisciplinary Management of Women Suffering from Migraine: Rationale, Design and Results of a National Delphi Consensus.

Healthcare (Basel, Switzerland)·2026
Same author

Elinzanetant for the Treatment of Menopausal Hot Flashes: A Plain Language Review of the OASIS-1-4 Clinical Trial Results.

Women's health (London, England)·2026
Same author

Consensus statement of dienogest as a progestin in contraception and non-contraceptive clinical entities (heavy menstrual bleeding, acne and hirsutism). Narrative review of the literature and recent developments.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2026
Same author

Knowledge of menopause-associated symptoms and non-hormonal strategies: an Italian survey on social media platforms.

Post reproductive health·2026
Same author

Prevention of Heart Failure in Women: An Expert Consensus Statement on Sex-Specific Risk Factors.

European journal of heart failure·2026
Same author

Correction: Early in, early out: reproductive lifespan timing and cardiometabolic risk in women.

Journal of endocrinological investigation·2026

相关实验视频

Updated: Jun 11, 2025

Establishment of an Experimental Mouse Model of Endometrioma to Study its Related Infertility
08:13

Establishment of an Experimental Mouse Model of Endometrioma to Study its Related Infertility

Published on: April 5, 2024

793

更年期和子宫内膜异位症.

Chiara Cassani1, Sara Tedeschi2, Laura Cucinella3

  • 1Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Viale Golgi 19, 27100 Pavia, Italy; Unit of Obstetrics and Gynecology, IRCCS S. Matteo Foundation, Viale Golgi 19, 27100 Pavia, Italy.

Maturitas
|October 2, 2024
PubMed
概括

绝经后子宫内膜异位症虽然不仅仅影响生育年龄的女性,但需要更多的研究. 手术切除是主要的治疗方法,但管理激素治疗和相关风险需要进一步研究.

关键词:
心血管疾病是什么心血管疾病子宫内膜异位症是什么?子宫内膜异位症是什么绝经期的激素治疗 (MHT)更年期 绝经 绝经癌症风险 癌症风险 癌症风险骨质疏松症是一种骨质疏松症.

更多相关视频

A Syngeneic Murine Model of Endometriosis using Naturally Cycling Mice
07:12

A Syngeneic Murine Model of Endometriosis using Naturally Cycling Mice

Published on: November 24, 2020

5.1K
Intraoperative Detection of Subtle Endometriosis: A Novel Paradigm for Detection and Treatment of Pelvic Pain Associated with the Loss of Peritoneal Integrity
07:20

Intraoperative Detection of Subtle Endometriosis: A Novel Paradigm for Detection and Treatment of Pelvic Pain Associated with the Loss of Peritoneal Integrity

Published on: December 21, 2012

15.9K

相关实验视频

Last Updated: Jun 11, 2025

Establishment of an Experimental Mouse Model of Endometrioma to Study its Related Infertility
08:13

Establishment of an Experimental Mouse Model of Endometrioma to Study its Related Infertility

Published on: April 5, 2024

793
A Syngeneic Murine Model of Endometriosis using Naturally Cycling Mice
07:12

A Syngeneic Murine Model of Endometriosis using Naturally Cycling Mice

Published on: November 24, 2020

5.1K
Intraoperative Detection of Subtle Endometriosis: A Novel Paradigm for Detection and Treatment of Pelvic Pain Associated with the Loss of Peritoneal Integrity
07:20

Intraoperative Detection of Subtle Endometriosis: A Novel Paradigm for Detection and Treatment of Pelvic Pain Associated with the Loss of Peritoneal Integrity

Published on: December 21, 2012

15.9K

科学领域:

  • 生殖医学 生殖医学
  • 妇科 妇科医生 妇科
  • 绝经研究 绝经研究

背景情况:

  • 子宫内膜异位症在绝经后患者中越来越多地被发现,这挑战了传统的观点,即它只发生在生育年龄的女性中.
  • 关于绝经后子宫内膜异位症的文献有限,导致其患病率,临床意义,最佳管理和预后存在不确定性.
  • 更年期患者的临床症状缺乏特异性,疼痛可以在任何生命阶段表现出来.

研究的目的:

  • 审查关于绝经后妇女子宫内膜异位症的当前文献.
  • 提供关于绝经后子宫内膜异位症的发病,症状,瘤风险,诊断和治疗的见解.
  • 为了解决围绕更年期人口中这种疾病管理的不确定性.

主要方法:

  • 这项研究是对现有文献的叙述性审查.
  • 它综合了有关绝经后子宫内膜异位症的现有研究.
  • 专注于致病,症状,瘤风险,诊断和治疗.

主要成果:

  • 手术切除仍然是症状性绝经后子宫内膜异位症的首要方法,有助于诊断和治疗,同时评估恶性瘤风险.
  • 由于更年期激素治疗的潜在禁忌和复发和恶性转变的风险,管理更年期后子宫内膜异位症是复杂的.
  • 由于潜在的恶性瘤风险,目前的建议建议结合更年期激素疗法或提博隆,而不是仅用雌激素治疗.

结论:

  • 需要进一步的研究,以澄清更年期期末激素治疗在有子宫内膜异位症史的女性中是否合适.
  • 患有子宫内膜异位症的绝经后妇女患有骨质疏松症和心血管疾病的潜在风险增加可能与早期手术绝经有关,因此需要进一步调查.
  • 了解子宫内膜异位症和更年期之间的复杂关系对于有效的诊断和治疗策略至关重要.